Your browser is no longer supported. Please, upgrade your browser.
Pulmonx Corporation
Index- P/E- EPS (ttm)-1.71 Insider Own15.60% Shs Outstand35.69M Perf Week-13.93%
Market Cap1.42B Forward P/E- EPS next Y-1.25 Insider Trans-11.33% Shs Float27.67M Perf Month-6.32%
Income-37.10M PEG- EPS next Q-0.37 Inst Own66.20% Short Float3.08% Perf Quarter-31.41%
Sales33.40M P/S42.43 EPS this Y-418.60% Inst Trans0.78% Short Ratio2.22 Perf Half Y-13.78%
Book/sh22.20 P/B1.82 EPS next Y18.10% ROA- Target Price60.14 Perf Year-
Cash/sh6.59 P/C6.12 EPS next 5Y46.70% ROE- 52W Range37.64 - 69.48 Perf YTD-41.54%
Dividend- P/FCF- EPS past 5Y- ROI-13.40% 52W High-41.92% Beta-
Dividend %- Quick Ratio19.10 Sales past 5Y- Gross Margin66.40% 52W Low7.20% ATR2.50
Employees170 Current Ratio20.00 Sales Q/Q-4.90% Oper. Margin-81.90% RSI (14)35.89 Volatility7.74% 5.64%
OptionableYes Debt/Eq0.08 EPS Q/Q-563.20% Profit Margin-82.70% Rel Volume1.33 Prev Close39.33
ShortableYes LT Debt/Eq0.08 EarningsMay 04 AMC Payout- Avg Volume384.44K Price40.35
Recom1.90 SMA20-9.46% SMA50-17.90% SMA200-21.82% Volume512,882 Change2.59%
Apr-01-21Initiated Citigroup Buy $60
Mar-25-21Initiated Piper Sandler Neutral $50
Mar-10-21Upgrade BofA Securities Neutral → Buy $72
Jan-04-21Downgrade BofA Securities Buy → Neutral
Oct-26-20Initiated Wells Fargo Equal Weight $46
Oct-26-20Initiated Stifel Buy $50
Oct-26-20Initiated Morgan Stanley Equal-Weight $44
Oct-26-20Initiated Canaccord Genuity Buy $49
Oct-26-20Initiated BofA Securities Buy $50
May-07-21 01:51AM  
May-05-21 04:31AM  
May-04-21 04:02PM  
Apr-27-21 04:05PM  
Apr-20-21 04:05PM  
Mar-10-21 10:03AM  
Mar-04-21 01:30AM  
Mar-02-21 10:00PM  
Feb-16-21 04:01PM  
Jan-28-21 09:02AM  
Jan-01-21 12:54AM  
Dec-08-20 08:13AM  
Nov-30-20 08:00AM  
Nov-10-20 04:01PM  
Nov-03-20 08:00AM  
Nov-02-20 10:00AM  
Oct-22-20 04:01PM  
Oct-05-20 04:01PM  
Oct-02-20 11:23AM  
Oct-01-20 12:09PM  
Sep-30-20 10:36PM  
Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rose Geoffrey BeranChief Commercial OfficerMay 10Sale40.704,797195,247116,673May 11 06:58 PM
Rose Geoffrey BeranChief Commercial OfficerApr 19Sale43.244,797207,422121,470Apr 21 05:26 PM
French Glendon E. IIIPresident and CEOApr 15Sale43.701,00043,70027,571Apr 16 05:03 PM
French Glendon E. IIIPresident and CEOApr 15Sale43.7525,0001,093,8561,224,884Apr 16 05:03 PM
Sung DerrickChief Financial OfficerApr 06Sale47.125,000235,602218,659Apr 06 07:40 PM
BOSTON SCIENTIFIC CORP10% OwnerApr 06Sale43.60650,00028,340,0003,988,106Apr 08 04:20 PM
Rose Geoffrey BeranChief Commercial OfficerApr 05Sale47.644,797228,521109,064Apr 06 07:41 PM
Sung DerrickChief Financial OfficerApr 05Sale47.605,000238,020223,659Apr 06 07:40 PM
Mead Dana G Jr.DirectorOct 05Buy19.0026,315499,98526,315Oct 05 04:16 PM
Melenikiotou GeorgiaDirectorOct 05Buy19.0026,315499,98526,315Oct 05 04:16 PM
FERRARI RICHARD MDirectorOct 05Buy19.0013,157249,98316,187Oct 05 04:16 PM
Florin Daniel PDirectorOct 05Buy19.0015,789299,99115,789Oct 05 04:17 PM